HOWL (Werewolf Therapeutics) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOWL Werewolf Therapeutics Inc HOWL
32 GF Score
Price $0.38
GF Value $3.78
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Werewolf Therapeutics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HOWL vs CVM, MRKR, ZIVO: Short Percentage of Float Comparison

For the Biotechnology subindustry, Werewolf Therapeutics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Werewolf Therapeutics Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Werewolf Therapeutics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Werewolf Therapeutics's Short Percentage of Float falls into.


HOWL
32GF Score
Werewolf Therapeutics Inc HOWL
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Werewolf Therapeutics (HOWL) Overvalued in 2026?

Based on GuruFocus' analysis, Werewolf Therapeutics stock appears to be undervalued. The current stock price of $0.38 is trading 89.9% below its estimated GF Value™ of $3.78. GuruFocus considers Werewolf Therapeutics to be Possible Value Trap.

Key valuation signals for HOWL:

  • Short Percentage of Float:
  • GF Value™: $3.78 vs. price of $0.38 (89.9% below fair value)
  • GF Score™: 32/100 with 2 warning signs

No single metric tells the full story. See the HOWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Werewolf Therapeutics Business Description

Address 200 Talcott Avenue, 2nd Floor, Watertown, MA, USA, 02472
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
32GF Score

Get the complete analysis for HOWL

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.38
Price
$3.78
GF Value